Elia's Selloff Hides the Capex Peak the Market Hasn't Priced

The market is still pricing Elia as an endless capital burner. The numbers already point to something different.

The Belgian-German electricity transmission operator posted its H1 2026 results on July 29 and the stock fell anyway. Adjusted profit rose 26% to €411 million. Net profit jumped 29% to €349 million. Full-year guidance was reaffirmed. And yet shares slipped nearly 3% on the day and have shed roughly 11% over the past three months, closing around €126 at the end of July.

The headlines are fixated on the debt and the capex. Net debt sits at €14.6 billion and the company just spent €1.9 billion on infrastructure in six months. Those numbers are real. But they are also the old story, and the financial bridge is changing underneath it.

The proof path: capex is peaking, not accelerating

The one number that shifts the reader's judgment is the capex revision. Management cut 2026 capital spending by €300 million to roughly €4.8 billion. About a quarter of that reflects genuine cost savings; the rest is rescheduling into later years. The underlying investment programme hasn't shrunk - but the timing tells you the peak is arriving, not deferred.

Put that against the five-year picture. Elia's 2024-2028 capex plan totals €31.6 billion. With the H1 spend already logged and the revised H2 guidance, roughly €7.5 billion remains across 2027 and 2028. That is a declining trajectory, not a flat one. For a regulated grid operator, declining capex against a growing asset base is the moment discretionary cash flow - the cash left after maintaining and expanding the grid - stops being a theoretical promise and starts showing up on the balance sheet.

Free cash flow was deeply negative through the build phase. In H1 2025 alone it ran to €540 million. S&P flagged very negative discretionary cash flows across the 2025-2027 window in a September 2025 update. That is the pain investors are still anchoring to. But the inflection is mechanical, not optional: the regulated asset base keeps growing, the return on that base is confirmed, and the capital programme is bending downward.

Regulatory certainty on one side, clarity arriving on the other

Belgium's regulatory framework for 2028-2031 is already locked. The cost-plus model (where the regulator allows a return on the invested asset base rather than leaving revenue to market risk) carries an average regulatory return of 8.1%, built on a Belgian 10-year bond rate of 3.4%. That is the floor for returns on the Belgian half of the business. No volume risk, no upside gamble.

Germany's framework is the open question. The Federal Network Agency is running consultations through October 2026, with a methodology decision expected in December 2026 and the ROE determination following by end-2027. The new period starts in 2029. That timeline means two full years of operating under known parameters before anything changes. And the German draft already proposes a cost-plus model with incentives, which is structurally closer to Belgium's settled approach than to the old fixed-revenue-cap systems that squeezed transmission operator margins in previous cycles.

The market is treating the German consultation as an unresolved risk that justifies a discount. It is a real risk - but a two-year window of operational clarity is longer than the discount implies.

The valuation bridge

Elia's full-year 2026 net profit guidance sits at €690 million to €740 million. On the 109 million-share base that translates to roughly €6.33 to €6.79 per share. At €126 the stock trades at around 19 times 2026 earnings. That is not cheap by historical utility standards. But it is not pricing in the free cash flow turnaround that should arrive as capex declines and the regulated asset base continues to compound.

If 2027 profit grows at a conservative 8% - a modest number given the asset growth trajectory - EPS pushes toward €6.90. Apply a 20x forward multiple, which is ungenerous for a regulated operator with an improving cash-flow profile, and you get €138. The consensus average price target is €145.50, with a high forecast of €170. Both sit above the current price because the math supports it, not because the sell side is being optimistic for its own sake.

What the selloff actually means

The recent weakness is tape pain, not business pain. Net debt at €14.6 billion looks large in a headline, but the cost of debt is 3% on a fully fixed-rate portfolio, and S&P's BBB rating carries a stable outlook. The financing structure is clean. The international and holding segment narrowed its adjusted loss to €3.2 million from €11.8 million a year earlier. The weakest part of the business is moving toward breakeven.

This is the setup the market misreads. It sees a capital-intensive utility with rising debt and discounts it accordingly. It does not fully price the fact that the capex cycle is bending, regulatory returns are confirmed in Belgium and nearing confirmation in Germany, and the FCF inflection is a mechanical consequence of those two forces colliding.

The scorecard

• Target: €140–145 over 12 months, based on 20x forward earnings on a modest 2027 growth path.
• Timeframe: 12 months from current levels.
• Tripwire: A German ROE determination below 6% would undermine the rerating thesis by compressing returns on the German half of the asset base. A renewed upward revision to capex guidance would signal the peak is not coming, which breaks the FCF bridge. Either condition would warrant stepping back.

Discipline over ego if the tripwire fires. But right now the setup is the opposite of what it looks like on the surface. The expectations have reset. The numbers haven't broken. The inflection is mechanical, not aspirational.